Home/Contractors/Dynport Vaccine Company LLC

Federal Contractor Profile

Dynport Vaccine Company LLC

Federal contracting record: $216M obligated across 36 awards from 2 agencies, FY 2016–2026.

$216M
Total Obligated
36
Award Records
2
Agencies Served
6
NAICS Codes
OverviewContractsAgenciesNAICS

Company Profile

UEI (Unique Entity Identifier)

LXNEGTYDR755

CAGE Code

1GFE1

Parent Organization

General Dynamics Corp

Address

64 THOMAS JOHNSON DR, FREDERICK, MD, 217024300

First Federal Award

Oct 15, 2015

Most Recent Award

Jan 23, 2026

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

  • Department of Defense

    95.2% of total obligations

    $205M

  • Department of Health and Human Services

    4.8% of total obligations

    $10M

Top NAICS Activity

  • 541711

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY

    18 awards

    $95M

  • 541712

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)

    5 awards

    $24M

  • 541715

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

    5 awards

    $21M

  • 541714

    RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)

    5 awards

    $11K

  • 541710

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES

    1 awards

    $0

  • 325414

    BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING

    1 awards

    -$7.2M

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Jan 23, 2026Department of DefenseARMY MED RES ACQ ACTIVITY541712IGF::OT::IGF - RESEARCH&DEVELOPMENT IN SUPPORT OF THE US ARMY MEDICAL MATERIEL DEVELOPMENT ACTIVITY (USAMMDA) FOR THE PERFORMANCE OF A PHASE I, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE LONG-TERM OPHTHALMIC SAFETY OF TAFENOQUINE VERSUS PLACEBO.$6K
Jan 14, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715TASK ORDER 75N93022F00001 BASE AWARD$219K
Dec 4, 2025Department of DefenseW6QK ACC-APG541715STABILITY TESTING$63K
Nov 18, 2025Department of DefenseW6QK ACC-APG541715STABILITY TESTING$264K
Sep 30, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715"EVALUATION AND TESTING SERVICES (ETS) FOR VACCINES AND OTHER BIOLOGICS FOR INFECTIOUS DISEASES.$10K
Jul 30, 2025Department of DefenseW6QK ACC-APG541715STABILITY TESTING$1.8M
Apr 23, 2025Department of DefenseW6QK ACC-APG541715STABILITY TESTING$533K
Apr 11, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541711PHASE 1$32K
Jan 28, 2025Department of DefenseW6QK ACC-APG541715STABILITY TESTING$372K
Jan 12, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715TASK ORDER 75N93022F00001 BASE AWARD$216K
Nov 14, 2024Department of DefenseW6QK ACC-APG541715STABILITY TESTING$264K
Sep 4, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541711PHASE I TASK AREA B -21-0013 - BASE$12K
Jul 22, 2024Department of DefenseW6QK ACC-APG541715STABILITY TESTING$1.7M
Jul 18, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541711PHASE 1$284K
Jul 2, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715EPCTU$246K
Jun 18, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541711PHASE I TASK AREA B -21-0013 - BASE$314K
May 31, 2024Department of DefenseW6QK ACC-APG541715STABILITY TESTING$858K
Apr 17, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541711PHASE I TASK AREA B -21-0013 - BASE$23K
Jan 25, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715EPCTU$219K
Jan 11, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541715TASK ORDER 75N93022F00001 BASE AWARD$212K
Dec 21, 2023Department of DefenseW6QK ACC-APG541715STABILITY TESTING$1.1M
Nov 16, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541711PHASE I TASK AREA B -21-0013 - BASE$508K
Aug 15, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541711PHASE 1$133K
Jul 10, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714DIAGNOSTIC PRE-CLINICAL SERVICES PROGRAM -IDIQ - DYNPORT$4K
Jul 10, 2023Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NIAID541714DIAGNOSTIC PRE-CLINICAL SERVICES PROGRAM -IDIQ - DYNPORT$4K

Top Compensated Officers

From FFATA executive compensation disclosures. Reported when federal contract activity exceeds the statutory threshold.

  • AMY GILLILAND

    Rank 1 · Reported Jan 23, 2026

    $4.9M

  • JULIE ASLAKSEN

    Rank 2 · Reported May 7, 2020

    $928K

  • PAUL NEDZBALA

    Rank 2 · Reported Apr 25, 2024

    $1.9M

  • KYLE MCNAMARA

    Rank 2 · Reported Jan 23, 2026

    $1.3M

  • LEIGH PALMER

    Rank 3 · Reported Apr 25, 2024

    $1.6M

  • TODD ROSSINI

    Rank 3 · Reported Jan 23, 2026

    $835K

  • KELLY FERRELL

    Rank 4 · Reported Apr 25, 2024

    $1.1M

  • TIMOTHY TURNER

    Rank 4 · Reported Jan 23, 2026

    $743K

  • NO FIFTH

    Rank 5 · Reported May 7, 2020

    $0

  • TIM TURNER

    Rank 5 · Reported Feb 22, 2022

    $699K

  • ALISON HARBRECHT

    Rank 5 · Reported Apr 25, 2024

    $1.1M

Subawards Paid Out

Dynport Vaccine Company LLC acts as a prime contractor and pays subcontractors on federal awards. Aggregated from USAspending sub-award reporting (FY2016-FY2026).

$6.0M
Total Paid to Subs
12
Sub Awards
6
Distinct Subawardees

Top 6 Subawardees

Related Contractors

Other companies active in NAICS 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY.

Alliance For Energy Innovation, LLC

$3.7B

Emergent Product Development Gaithersburg INC.

$264M

Battelle National Biodefense Institute, LLC

$170M

Hoffmann-la Roche INC.

$62M

Cerus Corporation

$37M

Merck Sharp & Dohme LLC

$33M

Glaxosmithkline, LLC

$23M

The Emmes Company, LLC

$21M

Track Dynport Vaccine Company LLC Recompetes Before They Post

Mindy monitors Dynport Vaccine Company LLC's active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.

Get Free Recompete Alerts